The Research Ethics Board (REB) is a joint venture between The Group Health Centre (GHC) and Sault Area Hospital (SAH), a collaboration which facilitates clinical research at these institutions. Our office at SAH serves as the administrative gateway for ethical review for both organizations.
An independent entity, the REB approves, rejects, proposes modifications to, or terminates any proposed or ongoing research involving GHC and/or SAH patients, staff, physicians, students, residents, and GHC/SAH information. Of utmost concern is the protection of patients, investigators, the institutions, and society. The REB also educates, supports, and mentors researchers regarding the process of ethical review.
As a joint organization, the membership of the REB consists of physicians and pharmacists from each agency, but also community members, such as lawyers, spiritual leaders, and privacy experts. These non-medical members ensure that all legal, religious, and psychological implications are considered and safeguarded during the course of research projects.
It is the duty of the REB to protect the rights, safety, and well-being of study participants at all phases of research projects undertaken at GHC and/or SAH. The REB is constituted by, and functions in accordance with, the International Conference on Harmonisation Good Clinical Practice, the Tri-Council Policy Statement 2, and other commonly-accepted standards, guidelines, and applicable legislation.
WHAT REQUIRES REB OVERSIGHT
In most cases, research undertaken at SAH and/or GHC by physicians, medical students, nurses, department managers, supportive care workers, or anyone else needs to receive prior REB approval before the project begins. Such projects may be varied, including, but not limited to:
However, not all research requires REB approval; for example, quality improvement initiatives for internal processes (i.e. LEAN projects) and some surveys (i.e. staff feedback on recent presentations) are exempt from REB review. Please contact our office at email@example.com for more information on determining whether a proposed research project requires REB oversight.
Many departments and employees at SAH and GHC undertake research, either self-initiated or sponsored. Studies can take many forms: testing new medications, performing interviews, reviewing patient charts, conducting surveys, and more. If you are interested in undertaking research at SAH and/or GHC, please contact the REB office at firstname.lastname@example.org to see if your project requires prior REB approval.
REB meetings are held over an extended lunch hour on a monthly basis from September to June of each year. Materials must be submitted by 4:00 p.m. at least 14 calendar days before the scheduled REB meeting. Submissions made after this cut-off date will not be reviewed by the REB until the next scheduled meeting in approximately two months.
The following is a schedule for 2018:
|March 1||February 15|
|April 5||March 22|
|May 3||April 19|
|June 28||June 14|
|September 6||August 23|
|October 4||September 20|
|November 1||October 18|
|December 6||November 22|
Additional Documents (where applicable):